ATXN7L3B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.113800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.722600E-01
Normal-vs-Stage2
4.871800E-01
Normal-vs-Stage3
1.882240E-01
Normal-vs-Stage4
5.225800E-01
Stage1-vs-Stage2
7.419800E-02
Stage1-vs-Stage3
2.154500E-02
Stage1-vs-Stage4
6.440400E-01
Stage2-vs-Stage3
3.024000E-01
Stage2-vs-Stage4
3.068400E-01
Stage3-vs-Stage4
1.590620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.431200E-01
Normal-vs-AfricanAmerican
6.451000E-01
Normal-vs-Asian
1.866560E-01
Caucasian-vs-AfricanAmerican
9.151600E-01
Caucasian-vs-Asian
2.069800E-01
AfricanAmerican-vs-Asian
4.289400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.062200E-01
Normal-vs-Female
6.040800E-01
Male-vs-Female
9.426200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.740400E-01
Normal-vs-Age(41-60Yrs)
8.187600E-01
Normal-vs-Age(61-80Yrs)
5.304200E-01
Normal-vs-Age(81-100Yrs)
3.607800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.921400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.095600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.467400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.372000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.947570E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.387600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.579010E-01
Normal-vs-Daily Drinker
5.106600E-01
Normal-vs-Weekly Drinker
3.801400E-01
Normal-vs-Occasional Drinker
9.969000E-01
Normal-vs-Social Drinker
9.434800E-01
Non Drinker-vs-Daily Drinker
6.662000E-01
Non Drinker-vs-Weekly Drinker
8.802000E-01
Non Drinker-vs-Occasional Drinker
4.866000E-02
Non Drinker-vs-Social Drinker
8.224500E-02
Daily Drinker-vs-Weekly Drinker
8.284400E-01
Daily Drinker-vs-Occasional Drinker
2.038000E-01
Daily Drinker-vs-Social Drinker
2.696800E-01
Weekly Drinker-vs-Occasional Drinker
1.509990E-01
Weekly Drinker-vs-Social Drinker
1.947220E-01
Occasional Drinker-vs-Social Drinker
9.083400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.374200E-02
Normal-vs-Grade 2
1.537950E-02
Normal-vs-Grade 3
1.498230E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.181800E-01
Grade 1-vs-Grade 3
6.985600E-01
Grade 1-vs-Grade 4
6.374200E-02
Grade 2-vs-Grade 3
8.956000E-01
Grade 2-vs-Grade 4
1.537950E-02
Grade 3-vs-Grade 4
1.498230E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.130400E-01
Normal-vs-NonDiabetic
5.582400E-01
Diabetic-vs-NonDiabetic
5.869000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.406400E-01
Normal-vs-NoPancreatitis
5.766800E-01
Pancreatitis-vs-NoPancreatitis
3.290200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.263400E-01
Normal-vs-N1
6.103600E-01
N0-vs-N1
9.796600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.345000E-01
Normal-vs-TP53-NonMutant
8.790600E-01
TP53-Mutant-vs-TP53-NonMutant
4.248400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
